DZUVEO

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Lithuania, Poland.

Active ingredients

The drug DZUVEO contains one active pharmaceutical ingredient (API):

1	Sufentanil UNII S9ZFX8403R - SUFENTANIL CITRATE
	Sufentanil is a synthetic, potent opioid with highly selective binding to μ-opioid receptors. Sufentanil acts as a full agonist in μ-opioid receptors. Sufentanil does not induce histamine release.
	Read more about Sufentanil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DZUVEO Sublingual tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01AH03	Sufentanil	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AH Opioid anesthetics
Discover more medicines within N01AH03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1775088, 1775099
LT	Valstybinė vaistų kontrolės tarnyba	1085930, 1085931
PL	Rejestru Produktów Leczniczych	100408130